NXP wants to keep the history of technology alive, which is why, for the past three years, they have been working with students from ArtEZ University of Applied Sciences to use old technologies and machines as a source of inspiration for art. In September the Expo was at Novio Tech Campus. Read more.
Khondrion announces that the first patients have been successfully dosed in its KHENEREXT Phase IIb open-label extension study
Khondrion, a clinical-stage biopharmaceutical company discovering and developing therapies targeting primary mitochondrial diseases, today announces that the first patients have been successfully dosed.